Editas Medicine, Inc.
EDIT
$2.82
$0.010.36%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -18.23M | -24.98M | -5.62M | -25.12M | -53.24M |
| Total Depreciation and Amortization | 416.00K | 483.00K | 805.00K | 721.00K | 1.83M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.10M | 3.29M | 1.64M | 4.57M | 5.81M |
| Change in Net Operating Assets | -14.85M | -1.85M | -33.21M | -11.01M | -4.62M |
| Cash from Operations | -29.57M | -23.06M | -36.39M | -30.84M | -50.21M |
| Capital Expenditure | -106.00K | -92.00K | -60.00K | -433.00K | 0.00 |
| Sale of Property, Plant, and Equipment | 0.00 | 156.00K | 118.00K | 0.00 | 151.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -29.69M | -- | 0.00 | 40.01M | 42.50M |
| Cash from Investing | -29.80M | 64.00K | 58.00K | 39.57M | 42.65M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 117.54M | -- | 17.33M | 17.17M | 7.41M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash from Financing | 117.54M | -- | 17.33M | 17.17M | 7.41M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 58.17M | -23.00M | -19.00M | 25.90M | -150.00K |